Outcomes of six dogs with prostate carcinoma and bacterial prostatitis treated with prostate artery embolization.

Concurrent bacterial prostatitis should not prevent prostatic artery embolization in dogs with prostatic carcinoma.

This retrospective case series evaluated outcomes of six dogs with concurrent bacterial prostatitis (BP) and prostatic carcinoma (PC) treated with prostatic artery embolization (PAE). All dogs received antibiotic therapy based on urine culture and sensitivity testing for a median of 7 weeks prior to PAE. Two dogs had positive urine cultures at the time of PAE. Post-procedure complications were minimal, with one dog developing a prostatic abscess and two dogs developing positive urine cultures after PAE. Median survival was 13 months (range 4.5-17 months), and notably, no dog died from infection-related complications. Urinary tract infection and BP occurred in only a minority of dogs and were not life-limiting. The findings suggest that concurrent BP and PC should not be considered contraindications to PAE treatment, as infectious complications were manageable and did not significantly impact survival outcomes in this cohort.

This summary was distilled by AI and may occasionally misinterpret data. Confirm critical details with the primary literature before clinical application.